The Claim
In adults with type 2 diabetes mellitus, 12 weeks of combined aerobic and resistance training has no significant effect on serum levels of pentraxin-related protein 3 or human cartilage glycoprotein 39.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Twelve weeks of combined aerobic and resistance exercise does not change the blood levels of pentraxin-related protein 3 or human cartilage glycoprotein 39 in adults with type 2 diabetes.
See the scientific wording
In adults with type 2 diabetes mellitus, combined aerobic and resistance training for 12 weeks does not significantly alter serum levels of pentraxin-related protein 3 or human cartilage glycoprotein 39, suggesting these markers are not responsive to this form of exercise intervention.
When adults with type 2 diabetes do combined aerobic and strength training, their immune cells reduce signals that trigger inflammation through the TLR4 and NF-κB pathway, which lowers some inflammatory proteins like IL-18. But this same process does not change the levels of two other proteins, PTX3 and YKL40, because those proteins are made by different cells and controlled by different signals that are not turned down by this kind of exercise.
What the research says
1 studyThe study found that after 12 weeks of cardio and strength training, two specific inflammation proteins (PTX3 and YKL40) didn’t change in people with type 2 diabetes — which means this kind of exercise doesn’t affect those particular markers.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.